3,4-DIHYDROXYBENZYLAMINE HYDROBROMIDE
UNII 9D6ZD7GA9A

Substance Identification & Data

This profile provides standardized clinical and technical data for 3,4-dihydroxybenzylamine Hydrobromide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9D6ZD7GA9A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 16290-26-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9D6ZD7GA9A

CAS Registry Number

16290-26-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

3,4-DIHYDROXYBENZYLAMINE HYDROBROMIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C7H9NO2.BrH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BVFZTXFCZAXSHN-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

13343562

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(c(ccc(c1)CN)O)O.Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3,4-dihydroxybenzylamine Hydrobromide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.